Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- Check7 days agoChange DetectedNew study locations were added (Hackensack Uni Medical Center; Esplugues, Barcelona, Spain, 08950) and an existing site name was updated from Hackensack University Medical Center / Esplugues de Llobregat, Barcelona, Spain to Esplugues, Barcelona, Spain, 08950.SummaryDifference0.5%

 - Check14 days agoNo Change Detected
 - Check22 days agoNo Change Detected
 - Check29 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

 - Check36 days agoChange DetectedMajor update to medical topic taxonomy: replaces broader leukemia/hematology terms with specific lymphoma and virus-related infections, and updates the revision version to v3.1.0.SummaryDifference2%

 - Check43 days agoChange DetectedCore location details and update timing have been expanded and reformatted (e.g., fuller postal address and added estimated update label).SummaryDifference0.3%

 - Check50 days agoChange DetectedRelease v3.0.2 with September 2025 data marked Actual; August 2025 data/estimates removed. Back to Top link removed.SummaryDifference0.6%

 - Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

 
Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.